ALS Dermatomyositis Laminopathy Muscle Centronuclear myopathy Cytokines Myotonic dystrophy type 1 Congenital muscular dystrophy Errance diagnostique CTG repeat contractions Autoantibodies Actin Lamin A/C Fabry disease Alternative splicing Genotype phenotype correlation Aging Myositis Regeneration Muscle regeneration Laminopathies COVID-19 Autophagy MBNL Myopathies Satellite cell CMS LMNA Trinucleotide repeat expansion Spinal muscular atrophy Antisense oligonucleotides Gene therapy CRISPRi Myotonic dystrophy Myoblasts Lamin A/C LMNA gene FSHD Thymus Glutamate Long read sequencing Becker muscular dystrophy DMD Myotonic Dystrophy RNA biology Neuromuscular diseases Skeletal muscle Outcome measures Transcriptomics LMNA gene Treatment Biomarkers Dilated cardiomyopathy Animals PABPN1 Thérapie génique OPMD Dystrophin Nuclear envelope Neuromuscular disease Heart failure Myogenesis Myotonic Dystrophy type 1 Rare neuromuscular diseases Fibrosis Rare diseases Cardiomyopathy Neuromuscular junction Laminopathie Autoimmune diseases Therapy Humans Myasthenia gravis Duchenne muscular dystrophy Biomarker Mouse model Congenital myopathy Inflammation AAV Myopathy RNA interference Autoimmunity Astrocyte Satellite cells Male Muscular dystrophy Calcium Myasthenia Gravis MG Exercise Motoneuron Brain Mice Dynamin 2 Genetics Mechanotransduction Cell therapy Cytoskeleton Heart Transgenic mouse model Aged Amyotrophic lateral sclerosis